Norihisa Kikuchi

851 citations
20 papers · 750 indexed · h-index 12

Norihisa Kikuchi

20 papers receiving 720 citations

Peers

Norihisa Kikuchi
Comparison fields: 5 of 81
  • Immunology 236
  • Oncology 153
  • Molecular Biology 360
  • Immunology and Allergy 27
  • Hematology 48
Replace Britta Hardy with:
Britta Hardy Israel
Jay S. Lillquist United States
J. K. Larsen Denmark
Hirokazu Hirata Japan
Sylvia Braselmann United States
Tracy Sawchuk Canada
Margaret S. Dordal United States
Dianzhong Luo China
Ingrid B.J. Joseph United States
Kunio Matsuta Japan
Norihisa Kikuchi relative to Britta Hardy Israel Britta Hardy's profile →
Citations per field
00.5×1.5×
Britta Hardy · 1×
Citations per year

Countries citing papers authored by Norihisa Kikuchi

Since Specialization
Citations

This map shows the geographic impact of Norihisa Kikuchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norihisa Kikuchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norihisa Kikuchi more than expected).

Fields of papers citing papers by Norihisa Kikuchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Norihisa Kikuchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norihisa Kikuchi. The network helps show where Norihisa Kikuchi may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Norihisa Kikuchi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Norihisa Kikuchi Line = papers co-authored together Norihisa Kikuchi links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20055
2 200268
3 19972
4 19962
5 19962
6 19961
7 1995163
8 19953
9 199437
10 199430
11 1994166
12 199266
13 199149
14 199120
15 198918
16 19876
17 198624
18 198557
19 198524
20 19857

About Norihisa Kikuchi

Norihisa Kikuchi is a scholar working on Immunology, Biotechnology and Oncology, having authored 20 papers that have together received 750 indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (5 papers), Pancreatic function and diabetes (5 papers), Neuropeptides and Animal Physiology (4 papers), Glycosylation and Glycoproteins Research (3 papers), Microbial Natural Products and Biosynthesis (2 papers), Pancreatitis Pathology and Treatment (2 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (2 papers) and Biochemical and Structural Characterization (2 papers). The work is most often cited by research in Immunology (236 citations), Oncology (153 citations) and Molecular Biology (360 citations). Norihisa Kikuchi has collaborated with scholars based in Japan and United States. Frequent co-authors include Osamu Ohara, Junji Kishino, H. Arita, K Higashino, Kohji Hanasaki, Jun Ishizaki, Hiroshi Teraoka, Kiyoshi Nagata, Toru Nakano and Koji Nomura. Their work appears in journals such as Journal of Biological Chemistry, The Journal of Biochemistry, FEBS Letters, Bioscience Biotechnology and Biochemistry and Applied Microbiology and Biotechnology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026